StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
109
This year
8
Publishing Date
2023 - 09 - 06
2
2023 - 07 - 24
2
2023 - 03 - 20
2
2023 - 02 - 22
2
2022 - 11 - 04
2
2022 - 08 - 15
2
2022 - 05 - 05
1
2022 - 05 - 03
1
2022 - 04 - 26
1
2022 - 04 - 25
1
2022 - 04 - 13
1
2022 - 04 - 11
1
2022 - 03 - 24
1
2022 - 03 - 21
1
2022 - 03 - 14
1
2022 - 03 - 10
1
2022 - 03 - 01
1
2022 - 01 - 04
1
2021 - 12 - 20
1
2021 - 11 - 30
2
2021 - 11 - 15
1
2021 - 11 - 10
1
2021 - 11 - 03
1
2021 - 10 - 26
1
2021 - 10 - 18
1
2021 - 09 - 30
1
2021 - 09 - 20
1
2021 - 09 - 15
1
2021 - 09 - 01
1
2021 - 08 - 10
1
2021 - 08 - 05
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 06 - 28
1
2021 - 06 - 22
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 15
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 05 - 03
1
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 20
2
2021 - 04 - 12
2
2021 - 03 - 29
1
2021 - 03 - 23
1
2021 - 03 - 17
1
2021 - 03 - 11
3
2021 - 03 - 09
1
2021 - 03 - 08
1
2021 - 03 - 01
1
2021 - 02 - 16
1
2021 - 01 - 21
1
2021 - 01 - 20
1
2020 - 12 - 28
1
2020 - 12 - 09
1
2020 - 12 - 08
1
Sector
Finance
1
Finance and insurance
1
Health services
1
Health technology
109
Information
9
Manufacturing
3
N/a
2
Process industries
2
Professional, scientific, and technical services
1
Technology services
2
Tags
3000
1
Aesthetic
1
Agreement
2
Alliances
7
Association
2
Biopharma
1
Biotech
3
Biotech-beach
26
Biotechnology
5
Business
6
Cancer
4
Cel
5
Cell
14
Clinical-trials-phase-i
5
Clinical-trials-phase-ii
7
Collaboration
2
Conference
13
Direct
2
Disease
3
Dmd
6
Drug
2
Earnings
6
Events
23
Financial
11
Financial results
9
Global
2
Growth
3
Immunotherapy
2
Innovation
2
Iot
3
Ipo
2
License
5
Macular
4
Market
2
Meeting
5
Million
2
Money
2
N/a
8
Offering
3
Opregen
12
Partnership
2
People
6
Phase 1
4
Potential
2
Preclinical
2
Presentation
6
Product-news
3
Report
12
Research
15
Results
30
Retina
5
Rg6501
11
Spinal cord
3
Study
3
Technology
2
Therapeutics
31
Therapy
11
Treatment
10
Update
11
Year
5
Entities
22nd century group, inc
1
Adc therapeutics sa
2
Advaxis, inc.
2
Agex therapeutics, inc.
2
Angiodynamics, inc.
2
Antares pharma, inc.
2
Boston scientific corporation
1
Brainsway ltd.
2
Cardiff oncology, inc.
1
Codexis, inc.
2
Coloplast a/s
1
Delcath systems, inc.
2
Eterna therapeutics inc
9
Geron corporation
2
Gossamer bio, inc.
3
Immune therapeutics, inc.
2
Immunogen, inc.
2
Kamada ltd.
2
Lineage cell therapeutics, inc.
109
London stock exchange group
1
Ocular therapeutix, inc.
1
Oncocyte corporation
3
Oncternal therapeutics, inc.
1
Pfizer, inc.
1
Smith micro software, inc.
1
Switch, inc.
1
Takeda pharmaceutical company limited
1
U.s. stem cell, inc.
1
Vericel corporation
1
Symbols
ABBV
156
ABEO
116
ADCT
145
AKBA
117
ALDX
123
ALLO
177
AMGN
137
AMRN
139
AQST
147
ATHE
106
AXSM
116
AZN
118
BCLI
131
BMY
131
BTAI
169
CALT
142
FATE
256
FULC
134
GILD
107
GOOG
198
GOOGL
198
GSK
151
GTHX
136
HOTH
109
HZNP
146
JNJ
531
KPTI
166
LCTX
109
LLY
284
MCRB
116
MDNA
109
MOR
191
MPSYF
187
MS
209
NKTR
371
NRIX
147
NTLA
112
NVS
226
NVSEF
192
OCX
183
ONTX
114
OTLK
148
PSTV
124
PSTX
110
PTCT
271
RLFTF
109
RLFTY
109
SNY
712
SNYNF
554
SPRO
121
SRNE
229
SRPT
165
TGTX
148
TVTX
122
TXMD
195
UTHR
144
VTGN
116
VXRT
186
VYNE
172
YMAB
178
Exchanges
Amex
109
Nasdaq
20
Nyse
6
Crawled Date
2023 - 09 - 06
2
2023 - 07 - 24
2
2023 - 03 - 20
2
2023 - 02 - 22
2
2022 - 11 - 04
2
2022 - 08 - 15
2
2022 - 05 - 05
1
2022 - 05 - 03
1
2022 - 04 - 26
1
2022 - 04 - 25
1
2022 - 04 - 13
1
2022 - 04 - 11
1
2022 - 03 - 24
1
2022 - 03 - 21
1
2022 - 03 - 14
1
2022 - 03 - 10
1
2022 - 03 - 01
1
2022 - 01 - 04
1
2021 - 12 - 20
1
2021 - 11 - 30
2
2021 - 11 - 15
1
2021 - 11 - 10
1
2021 - 11 - 03
1
2021 - 10 - 26
1
2021 - 10 - 18
1
2021 - 09 - 30
1
2021 - 09 - 20
1
2021 - 09 - 15
1
2021 - 09 - 01
1
2021 - 08 - 10
1
2021 - 08 - 05
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 06 - 28
1
2021 - 06 - 22
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 15
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 05 - 03
1
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 20
2
2021 - 04 - 12
2
2021 - 03 - 29
1
2021 - 03 - 23
1
2021 - 03 - 17
1
2021 - 03 - 11
3
2021 - 03 - 09
1
2021 - 03 - 08
1
2021 - 03 - 01
1
2021 - 02 - 17
1
2021 - 01 - 21
1
2021 - 01 - 20
1
2020 - 12 - 28
1
2020 - 12 - 09
1
2020 - 12 - 08
1
Crawled Time
00:00
3
11:02
1
12:00
6
12:20
3
12:30
3
13:00
33
13:15
5
13:20
6
13:30
4
14:00
14
14:30
1
15:00
7
15:30
1
16:00
1
16:01
1
17:00
3
17:01
1
18:00
1
19:00
3
19:01
1
21:00
1
22:00
2
22:01
1
23:00
6
23:03
1
Source
www.biospace.com
101
www.globenewswire.com
5
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
symbols :
Lctx
save search
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
Published:
2024-03-18
(Crawled : 16:00)
- biospace.com/
ERNA
|
$1.8
-8.16%
-8.89%
12K
|
Information
|
-10.09%
|
O:
-0.92%
H:
9.26%
C:
8.8%
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-11.63%
|
O:
-3.88%
H:
1.61%
C:
-5.65%
symposium
cell
therapeutics
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Published:
2024-03-13
(Crawled : 13:00)
- biospace.com/
ERNA
|
$1.8
-8.16%
-8.89%
12K
|
Information
|
-19.67%
|
O:
4.1%
H:
0.0%
C:
-11.81%
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-8.06%
|
O:
1.61%
H:
2.38%
C:
-3.97%
rg6501
opregen
innovation
cell
therapy
results
study
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
ERNA
|
$1.8
-8.16%
-8.89%
12K
|
Information
|
-11.48%
|
O:
1.17%
H:
10.27%
C:
10.27%
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-12.31%
|
O:
-5.38%
H:
17.89%
C:
4.88%
rg6501
opregen
association
research
preclinical
vision
meeting
results
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published:
2024-03-07
(Crawled : 23:00)
- biospace.com/
ERNA
|
$1.8
-8.16%
-8.89%
12K
|
Information
|
1.09%
|
O:
3.16%
H:
0.0%
C:
-0.5%
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
0.88%
|
O:
1.77%
H:
0.0%
C:
-1.74%
business
year
update
cell
therapeutics
financial
results
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
Published:
2024-02-29
(Crawled : 15:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
9.62%
|
O:
1.92%
H:
1.89%
C:
-1.89%
report
business
year
update
cell
therapeutics
financial
results
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Published:
2024-02-13
(Crawled : 14:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
5.56%
|
O:
1.85%
H:
0.83%
C:
-7.27%
fda
cell
treatment
clearance
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
Published:
2024-02-09
(Crawled : 15:30)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
5.56%
|
O:
5.56%
H:
0.88%
C:
-5.26%
million
direct
cell
offering
therapeutics
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
Published:
2024-02-06
(Crawled : 15:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
9.62%
|
O:
2.88%
H:
7.48%
C:
3.74%
million
direct
cell
offering
therapeutics
Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury
Published:
2023-12-18
(Crawled : 14:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
25.26%
|
O:
1.66%
H:
17.81%
C:
14.57%
drug
treatment
submission
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published:
2023-11-09
(Crawled : 00:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
3.64%
|
O:
0.91%
H:
2.69%
C:
-3.6%
business
update
cell
therapeutics
financial
results
Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023
Published:
2023-11-01
(Crawled : 13:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
0.0%
|
O:
0.0%
H:
0.88%
C:
-1.75%
report
business
update
cell
therapeutics
financial
results
RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at Eyecelerator at 2023 American Academy of Ophthalmology (AAO) Annual Meeting
Published:
2023-10-24
(Crawled : 12:30)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-1.72%
|
O:
2.59%
H:
0.84%
C:
-0.84%
rg6501
opregen
meeting
results
Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells
Published:
2023-10-11
(Crawled : 13:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-14.93%
|
O:
-1.49%
H:
0.76%
C:
-3.03%
patent
RG6501 (OpRegen®) Phase 1/2a Results Show Evidence of Rapid Improvement of Outer Retinal Structure in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Published:
2023-10-05
(Crawled : 13:30)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-5.0%
|
O:
1.67%
H:
9.84%
C:
8.2%
rg6501
opregen
macular
rapid
results
show
Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023
Published:
2023-09-19
(Crawled : 14:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-12.98%
|
O:
0.76%
H:
1.14%
C:
-2.27%
conference
global
RG6501 (OpRegen®) Phase 1/2a Additional Results to Be Featured at 23rd EURETINA Congress
Published:
2023-09-13
(Crawled : 12:30)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-13.64%
|
O:
1.52%
H:
0.74%
C:
-2.24%
rg6501
opregen
congress
results
Lineage to Present at 2023 International Spinal Research Trust Network Meeting
Published:
2023-09-11
(Crawled : 13:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-16.18%
|
O:
-2.21%
H:
3.01%
C:
0.0%
international
research
meeting
network
trust
Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics
Published:
2023-09-06
(Crawled : 15:00)
- biospace.com/
ERNA
|
$1.8
-8.16%
-8.89%
12K
|
Information
|
-15.15%
|
O:
5.63%
H:
5.73%
C:
-6.14%
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-17.39%
|
O:
0.72%
H:
0.72%
C:
-2.88%
partnership
cell
therapeutics
Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
Published:
2023-09-06
(Crawled : 12:00)
- globenewswire.com
ERNA
|
$1.8
-8.16%
-8.89%
12K
|
Information
|
-15.15%
|
O:
5.63%
H:
5.73%
C:
-6.14%
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-17.39%
|
O:
0.72%
H:
0.72%
C:
-2.88%
partnership
cell
therapeutics
Lineage Cell Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Update on August 10, 2023
Published:
2023-08-03
(Crawled : 13:00)
- biospace.com/
LCTX
|
$1.1
-3.51%
0.0%
740K
|
Health Technology
|
-17.99%
|
O:
-1.44%
H:
6.57%
C:
2.92%
report
business
update
cell
therapeutics
financial
results
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.